Clinical Trial Update: Multi-center, Open-label, Phase 1b Clinical Trial to Evaluate the Safety, Tolerability, and Exploratory Efficacy of TEW-7197 in Combination With FOLFOX in Patients With Metastatic Pancreatic Ductal Adenocarcinoma Who Have Failed First-Line Gemcitabine and Nab-Paclitaxel [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/Phase 2 open-label trial evaluating TEW-7197 in combination with FOLFOX for metastatic pancreatic ductal adenocarcinoma after failure of gemcitabine/na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• FOLFOX
• TEW-7197 (TEW-7197)

Snippet

Sponsor: Joon Oh Park | Conditions: Metastatic Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN